Please be advised that as of April 27, 2026, Sterling IRB’s mailing address has changed from:
Sterling Institutional Review Board
5500 Interstate North Parkway
Suite 515
Atlanta, GA 30328
To:
Sterling Institutional Review Board
6300 Powers Ferry Road
Suite 600 – 351
Atlanta, GA 30339
Any references to our mailing address in agreements between Sterling Institutional Review Board and your company shall be deemed the new address as listed above. All mail, including paper checks (if applicable), should be sent to the new mailing address listed above.
Per the FDA Information Sheet – Frequently Asked Questions – Statement of Investigator (Form FDA 1572), currently approved sites, as well as sites pending approval, do not need to update their 1572s. If your site was approved after our move date of April 27, 2026, and your site had already submitted the 1572 with our old address or forgot to update our address, you do not need to send the FDA a revised 1572.
Please file this memorandum with the regulatory documents for this study.
If you have any questions, please feel free to reach out to us at [email protected] or 888-636-1062.
We thank you for your continued partnership with Sterling IRB.